Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants

Completed · Phase 3 · Has a placebo group

Conditions studied: Lung Diseases, Bronchopulmonary Dysplasia

In brief

To determine whether or not inhaled nitric oxide (iNO) safely decreases the incidence of chronic lung disease (CLD) in premature infants.

Key facts

Study ID
NCT00006401
Run by
University of Colorado, Denver
People needed
793
Starts
2000-09-01
Expected to finish
2007-10-01
Last updated by the study team
2015-10-06

Who can join

Age: any, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.